Major Indian Pharma Exporters (Most Affected)
Sun Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories Ltd.
Cipla Ltd.
Lupin Ltd.
Aurobindo Pharma Ltd.
Zydus Lifesciences Ltd. (formerly Cadila Healthcare)
Torrent Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd.
Alkem Laboratories Ltd.
Intas Pharmaceuticals Ltd.
API & Bulk Drug Manufacturers
Divi’s Laboratories Ltd.
Laurus Labs Ltd.
Granules India Ltd.
Neuland Laboratories Ltd.
MBH/AB
Good to know!! Informative
Very informative.
Donald Trump has imposed tariffs on various goods, and one of the major industries affected is the pharmaceutical industry. These tariffs can create challenges in the import of raw materials and the export of medicines.
Hopefully, these issues will be resolved soon for smoother global trade in healthcare products.
The pharmaceutical companies you’ve listed are some of India’s largest and most significant players, with a strong global presence. Their business is heavily influenced by international markets, particularly the US, which is the top destination for Indian pharma exports. This makes them susceptible to global market changes and trade policies.
Trump’s proposed tariff on Indian pharmaceutical imports could significantly impact major exporters like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Aurobindo. API and bulk drug manufacturers such as Divi’s, Laurus Labs, and Granules India would also face increased costs and reduced competitiveness in the U.S. market.
Informative
Very informative! It gives us great insight into the various pharmaceutical companies and their business models.
Very informative
Very informative! And these are all major pharma companies too